Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 20, 2011
Finance
Analyst tracks
...in equity research covering biotechnology and specialty pharmaceuticals companies. He was a managing director with
Hapoalim Securities
. ...
Read More
BioCentury
|
Apr 19, 2010
Analyst Picks & Changes
Analyst picks & changes
...raised $64.4M in an IPO and concurrent private placement last month. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL)
Hapoalim Securities
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Jun 20, 2011
Finance
Analyst tracks
...in equity research covering biotechnology and specialty pharmaceuticals companies. He was a managing director with
Hapoalim Securities
. ...
Read More
BioCentury
|
Apr 19, 2010
Analyst Picks & Changes
Analyst picks & changes
...raised $64.4M in an IPO and concurrent private placement last month. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL)
Hapoalim Securities
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page